RPS6KB1 and mantle cell lymphoma: Additionally, we recently reported that activation of PI3K and its downstream mTOR/p70S6K pathway contribute to BTZ resistance in MCL, demonstrating that inhibition of PI3K and mTOR is essential to overcome BTZ resistance [43].